Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Eptacog alfa (activated)

EU orphan designation number: EU/3/07/436
Active ingredient: Eptacog alfa (activated)
Indication: Treatment of post-neonatal intracerebral haemorrhage
Sponsor: Novo Nordisk A/S
Novo Allé, 2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2007 Orphan designation EMEA/OD/089/06 (2007)1323 of 20/03/2007
23/06/2011 Removal of orphan designation from Community Register